TY - JOUR
T1 - Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
JO - Frontiers in Oncology
UR - https://doi.org/10.3389/fonc.2025.1556881
PY - 2025/04/02
AU - Saha S
AU - Gerdtham U-G
AU - Sj枚dahl G
AU - H盲ggstr枚m C
AU - Catto JWF
AU - Kelly JD
AU - Ull茅n A
AU - Holmberg L
AU - Liedberg F
ED -
DO - DOI: 10.3389/fonc.2025.1556881
PB - Frontiers Media SA
VL - 15
Y2 - 2025/06/19
ER -